Guilluame Luxardi

10PUBLICATIONS
40CO-AUTHORS
Haematological tumoursCell development, proliferation and deathNeural engineeringCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Joseph M Tuscano, Tamer Othman, Paul Frankel

|Nov 10, 2025
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Joseph M Tuscano, Tamer Othman, Paul Frankel

|Apr 30, 2025
Hypoglycemia promotes inner blood-retinal barrier breakdown and retinal vascular leakage in diabetic mice.

Chuanyu Guo, Yueqi Niu, Xuemei Pan

|Jan 17, 2025
Stimulating the regenerative capacity of the human retina with proneural transcription factors in 3D cultures.

Juliette Wohlschlegel, Faith Kierney, Kayla L Arakelian

|Sep 01, 2023
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial.

Arta M Monjazeb, Megan E Daly, Guillaume Luxardi

|Jun 05, 2021
Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma.

Joseph M Tuscano, Christina Poh, Paul Kaesberg

Pageof 2

Frequent Collaborators

3 joint publications

Alexander Merleev

2 joint publications

Elad Sharon

2 joint publications

L Elizabeth E Budde

2 joint publications

Dipenkumar Modi